Home/Filings/4/0000899243-23-014866
4//SEC Filing

Shin Nippon Biomedical Laboratories, Ltd. 4

Accession 0000899243-23-014866

CIK 0001692830other

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 4:24 PM ET

Size

10.0 KB

Accession

0000899243-23-014866

Insider Transaction Report

Form 4
Period: 2023-06-06
Transactions
  • Purchase

    Common Stock

    2023-06-06$0.91/sh+22,053,581$20,068,75922,053,581 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2023-06-08$0.91/sh+8,423,732$7,665,5968,423,732 total(indirect: See Footnote)
Holdings
  • Common Stock

    2,560,780
  • Common Stock

    (indirect: See Footnote)
    233,333
Footnotes (5)
  • [F1]All of the shares were cancelled on June 8, 2023 pursuant to the terms of that certain Agreement and Plan of Merger, dated as of April 16, 2023 (the "Merger Agreement"), by and among Shin Nippon Biomedical Laboratories, Ltd. ("SNBL"), SNBL23 Merger Sub, Inc., a wholly owned subsidiary of SNBL ("Merger Sub"), and Satsuma Pharmaceuticals, Inc. ("Satsuma"). Following effectiveness of the merger provided for in the Merger Agreement, SNBL owns 1000 shares of the common stock of Satsuma, which represents all of the outstanding shares of common stock of Satsuma. As a result of the merger, Satsuma became a wholly owned subsidiary of SNBL.
  • [F2]Shares acquired by Merger Sub, upon acceptance of all shares validly tendered and not validly withdrawn pursuant to the tender offer by Merger Sub and SNBL, pursuant to the Merger Agreement, for any and all outstanding shares of Satsuma common stock pursuant to that certain Offer to Purchase, dated May 5, 2023.
  • [F3]Shares acquired pursuant to the merger provided for in the Merger Agreement.
  • [F4]SNBL acquired an aggregate of 2,560,780 shares of common stock of Satsuma in transactions on July 1, 2016, February 1, 2018, and April 22, 2019.
  • [F5]SNBL U.S.A., Ltd., a wholly owned subsidiary of SNBL acquired an aggregate of 233,333 shares of common stock of Satsuma in a transaction on September 13, 2019.

Issuer

Satsuma Pharmaceuticals, Inc.

CIK 0001692830

Entity typeother
IncorporatedJapan

Related Parties

1
  • filerCIK 0001657770

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 4:24 PM ET
Size
10.0 KB